AstraZeneca may have provided incomplete efficacy data from latest COVID-19 trial -NIAID

AstraZeneca may have provided incomplete efficacy data from latest COVID-19 trial -NIAID AstraZeneca said a day earlier that its COVID-19 vaccine developed with Oxford University was 79% effective in preventing symptomatic illness in a large trial in the United States, Chile and Peru. https://ift.tt/eA8V8J